戻る Agendas
Session 0306 Clinical Science - II - IMCT Latest Guidance: Population PK Value in Development
Session Chair(s)
Paul Dai, MD
Head of Clinical Operations
TDC, Asia, Takeda, China
Speaker(s)
Early Phase Development Design Strategy3 DIA7 Bashaw (NXPowerLite Copy)
E. Dennis Bashaw, PHARMD
FDA, United States
Senior Science Advisor, Office of Clinical Pharmacology
Early phase development strategy & value of model based drug development
Hartmut Blode
Bayer Healthcare Co.,Ltd., China
Head of Clinical Pharmacology Asia/ Primary Care
Considerations for First-in-Man (FIM) Studies
Peiming Ma
GSK China, China
Senior Director, Clinical Pharmacology, R&D Center